UNITED THERAPEUTICS Corp Earnings Per Share Diluted

• UNITED THERAPEUTICS Corp showed an increase of +13.1% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from UNITED THERAPEUTICS Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 18 years of available data (2008 to 2025), UNITED THERAPEUTICS Corp's Earnings Per Share Diluted has grown by 2,679.6%.
• Historical annual values: Fiscal year 2025: $27.86 per share | Fiscal year 2024: $24.64 per share | Fiscal year 2023: $19.81 per share | Fiscal year 2022: $15.00 per share | Fiscal year 2021: $10.06 per share | Fiscal year 2020: $11.54 per share | Fiscal year 2019: $2.39 (loss) per share | Fiscal year 2018: $13.39 per share | Fiscal year 2017: $9.31 per share | Fiscal year 2016: $15.25 per share | Fiscal year 2015: $12.72 per share | Fiscal year 2014: $6.28 per share | Fiscal year 2013: $3.28 per share | Fiscal year 2012: $5.71 per share | Fiscal year 2011: $3.67 per share | Fiscal year 2010: $1.78 per share | Fiscal year 2009: $0.35 per share | Fiscal year 2008: $1.08 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026